Friedberg, Germany

Katharina Lutterbeck

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Katharina Lutterbeck

Introduction

Katharina Lutterbeck is an accomplished inventor based in Friedberg, Germany. With a total of four patents to her name, she has made significant contributions to the field of pharmaceutical sciences. Her innovative approaches focus on the coupling of proteins and low-molecular substances to modified polysaccharides, paving the way for new therapeutic possibilities.

Latest Patents

Katharina's latest patents showcase her expertise in biochemistry and pharmaceutical applications. One notable invention is a method for coupling proteins to a modified polysaccharide. This method involves a covalent bond formed through a coupling reaction between the terminal aldehyde group of the polysaccharide and a functional group of the protein. Such conjugates have critical applications in pharmaceutical compositions for the prophylaxis or therapy of humans and animals.

Another important patent details a method for coupling low-molecular substances to a modified polysaccharide. Similar to her work with proteins, this method relies on the formation of covalent bonds through specific chemical reactions. The conjugates resulting from this process can also be utilized in pharmaceutical compositions, further enhancing therapeutic options for medical treatments.

Career Highlights

Currently, Katharina Lutterbeck is associated with Fresenius Kabi Deutschland GmbH, a company renowned for its innovations in the field of pharmaceuticals and biomedicine. Her work at the company emphasizes the critical intersection of biochemistry and drug development, directly contributing to advancements in medicine and treatment efficacy.

Collaborations

Throughout her career, Katharina has collaborated with esteemed colleagues such as Jurgen Hemberger and Michele Orlando. These partnerships have enabled her to enhance her research and development efforts, leading to successful patent applications and innovations in complex pharmaceutical solutions.

Conclusion

Katharina Lutterbeck stands out as a significant figure in the realm of pharmaceutical inventions. Her insightful methods for coupling proteins and low-molecular substances to modified polysaccharides not only reflect her technical skill but also her commitment to advancing therapeutic applications. Her contributions to Fresenius Kabi Deutschland GmbH and her collaboration with other professionals underscore the importance of teamwork in driving innovation within the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…